{"id":"W3009824331","doi":"10.7573/dic.2019-11-4","title":"Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection","year":2020,"lang":"en","type":"review","venue":"Drugs in Context","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Regina; McGill University; Jewish General Hospital","funders":"","keywords":"Reverse-transcriptase inhibitor; Lamivudine; Medicine; Regimen; Nucleoside Reverse Transcriptase Inhibitor; Virology; Drug resistance; Nucleoside; Clinical trial; Pharmacology; Human immunodeficiency virus (HIV); Virus; Sida; Internal medicine; Antiretroviral therapy; Viral disease; Biology; Viral load; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003559752,0.0004256477,0.001567546,0.0002497838,0.00008192233,0.00002897266,0.00007516965,0.0002197756,0.00001724683],"category_scores_gemma":[0.0001396897,0.0002643264,0.0005092448,0.0003533995,0.0001604997,0.0001207783,0.00001552969,0.0002703829,0.00005319678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002524884,"about_ca_system_score_gemma":0.0003232387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000020131,"about_ca_topic_score_gemma":0.00004096842,"domain_scores_codex":[0.9978215,0.0000712416,0.001317086,0.0003502725,0.0002232673,0.0002166693],"domain_scores_gemma":[0.9982854,0.0007908102,0.000387049,0.0003056279,0.00008591769,0.0001451616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007812123,0.0008013686,0.0001296468,0.005678844,0.000538793,0.000008634245,0.001703231,1.503552e-7,8.637874e-7,0.0002035635,0.008395529,0.9817582],"study_design_scores_gemma":[0.007478927,0.0004492034,0.00005775946,0.006380989,0.001793842,0.00000565014,0.0001727498,0.00005200688,0.00002256472,0.000004151042,0.9833794,0.0002027647],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005501093,0.9854116,0.0002908087,0.00355684,0.0006227951,0.007986691,0.0006383547,0.00005361618,0.0008891299],"genre_scores_gemma":[0.0007215695,0.9951049,0.0007124695,0.0003536277,0.0001797319,0.0007762581,0.0003242146,0.00003496592,0.001792247],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9815554,"threshold_uncertainty_score":0.9999809,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07832152487031797,"score_gpt":0.3881401415408423,"score_spread":0.3098186166705243,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}